Kriton Medical Inc.

by Mary Thompson After struggling for years to gain momentum, the ventricular assist device (VAD) market appears finally to be coming of age. Second-generation VAD designs are performing well and seem

In medical devices today, consolidation tends to happen for two reasons. In mature product segments, successful companies consolidate from a position of strength to maintain their market dominance. In

If a new generation of implantable devices can function reliably for many years, they may offer CHF patients an alternative to heart transplantation and even arrest the progression of the disease. by

For congestive heart failure patients, the only cure today is a heart transplant. But Kriton Medical Inc. hopes to offer a new alternative to transplantation, with a miniature, completely implantab